Beijing Chest Hospital, Capital Medical University, Beijing Key Laboratory for Drug Resistant Tuberculosis Research, Beijing Tuberculosis and Thoracic Tumor Research Institute, Beijing 101100, China.
Diagn Microbiol Infect Dis. 2013 Jul;76(3):309-13. doi: 10.1016/j.diagmicrobio.2013.03.030. Epub 2013 May 4.
The aim of this study was to assess the value of interferon-γ (IFN-γ) release assay (IGRA) (T-SPOT.TB) for patients with suspected osteoarticular tuberculosis (TB) in comparison with conventional and molecular methods. Of 145 patients with suspected osteoarticular TB, recruited from Beijing Chest Hospital between July 2011 and June 2012, 86 (59.3%)had osteoarticular TB (26 with culture-confirmed TB, 60 with probable TB), 24 (16.6%) were not having active TB. The remaining 17 (11.7%) inconclusive TB and 18 (12.4%) possible TB were excluded from final analysis. In addition to conventional tests and molecular method, T-SPOT.TB assay using peripheral blood mononuclear cells to examine IFN-γ response to early secretory antigenic target 6 and culture filtrate protein 10 was also performed. The sensitivity and specificity for T-SPOT.TB assay were 94.2% and 70.8%, respectively. A statistically significant difference in sensitivity was found between T-SPOT.TB assay (94.2%) and other tests (acid-fast bacilli smear (19.7%), culture (34.2%), real-time PCR (36.8%); P < 0.01, respectively). These results suggested that the IGRA assay could provide useful aids in the diagnosis of osteoarticular TB.
本研究旨在评估干扰素-γ(IFN-γ)释放试验(IGRA)(T-SPOT.TB)在疑似骨关节结核(TB)患者中的应用价值,并与常规和分子方法进行比较。2011 年 7 月至 2012 年 6 月,我们在北京胸科医院招募了 145 例疑似骨关节结核患者,其中 86 例(59.3%)患有骨关节结核(26 例培养确诊的 TB,60 例可能的 TB),24 例(16.6%)没有活动性 TB。其余 17 例(11.7%)为不确定 TB,18 例(12.4%)为可能 TB,这些病例被排除在最终分析之外。除了常规检测和分子方法外,还使用外周血单核细胞检测 IFN-γ 对早期分泌抗原靶 6 和培养滤液蛋白 10 的反应,进行 T-SPOT.TB 检测。T-SPOT.TB 检测的敏感性和特异性分别为 94.2%和 70.8%。T-SPOT.TB 检测(94.2%)与其他检测(抗酸杆菌涂片(19.7%)、培养(34.2%)、实时 PCR(36.8%))的敏感性存在统计学显著差异(P<0.01)。这些结果表明,IGRA 检测可在骨关节结核的诊断中提供有用的辅助。